Journal of Developing Drugs
Open Access

The future of quality generic pharmaceutical manufacturing in Asia: A clash of cultures?

International Conference and Expo on Generic Drug Market & Contract Manufacturing

November 07-09, 2016 Barcelona, Spain

Alan Liss

GXP Farma, LLC�Consulting, USA

Posters & Accepted Abstracts: J Develop Drugs

Abstract :

Global pharmaceutical trends confirm the importance of Asian pharmaceutical manufacturing facilities as the most critical aspect of maintaining the supply of many of the drugs currently on the market. However, recurring issues in regard to product quality and general compliance to established quality standards put a potential cloud over the otherwise bright future of this region of the pharma world. This presentation shall summarize information gained while a member of US FDA and as a current subject matter expert in Asia regarding current, present and future compliance to regulatory standards in key Asian markets. Data emphasis will be on small molecule generics but with a critical evaluation of the future of biosimilars produced in these same areas. The connection between pharmaceutical standards and cultural norms will be made and how these will affect the future of manufacturing in Asia, specifically and the global pharmaceutical supply chain in general.

Biography :

Email: lissnest@yahoo.com